briefli amgen loss mount amgen chief execut said thousand oak biotechnolog compani face loss million dollar fiscal year end month court rule could delay feder approv amgen new anti anemia drug gordon binder said loss would exceed 10 million amgen expect fourth quarter sale drug call erythropoietin epo offset start cost amgen su market partner feder judg last week order amgen submit data u food drug administr could delay fda approv drug